- Home
- PCRX vs TBLA Comparison
PCRX vs TBLA Comparison
Compare PCRX & TBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- TBLA
- Stock Information
- Founded
- PCRX 2006
- TBLA 2007
- Country
- PCRX United States
- TBLA United States
- Employees
- PCRX N/A
- TBLA N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- TBLA Computer Software: Programming Data Processing
- Sector
- PCRX Health Care
- TBLA Technology
- Exchange
- PCRX Nasdaq
- TBLA Nasdaq
- Market Cap
- PCRX 1.2B
- TBLA 1.2B
- IPO Year
- PCRX 2011
- TBLA N/A
- Fundamental
- Price
- PCRX $25.12
- TBLA $3.34
- Analyst Decision
- PCRX Buy
- TBLA Strong Buy
- Analyst Count
- PCRX 9
- TBLA 4
- Target Price
- PCRX $29.89
- TBLA $4.33
- AVG Volume (30 Days)
- PCRX 782.0K
- TBLA 1.9M
- Earning Date
- PCRX 05-08-2025
- TBLA 05-07-2025
- Dividend Yield
- PCRX N/A
- TBLA N/A
- EPS Growth
- PCRX N/A
- TBLA N/A
- EPS
- PCRX N/A
- TBLA 0.04
- Revenue
- PCRX $702,772,000.00
- TBLA $1,779,705,000.00
- Revenue This Year
- PCRX $9.48
- TBLA $7.23
- Revenue Next Year
- PCRX $11.31
- TBLA $10.56
- P/E Ratio
- PCRX N/A
- TBLA $83.98
- Revenue Growth
- PCRX 3.08
- TBLA 16.63
- 52 Week Low
- PCRX $11.16
- TBLA $2.50
- 52 Week High
- PCRX $31.67
- TBLA $4.60
- Technical
- Relative Strength Index (RSI)
- PCRX 48.10
- TBLA 70.53
- Support Level
- PCRX $25.08
- TBLA $2.91
- Resistance Level
- PCRX $27.34
- TBLA $3.43
- Average True Range (ATR)
- PCRX 1.16
- TBLA 0.14
- MACD
- PCRX -0.18
- TBLA 0.05
- Stochastic Oscillator
- PCRX 48.85
- TBLA 82.35
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About TBLA Taboola.com Ltd.
Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, Germany, France, Rest of the world whilst it generates the majority of its revenue from the United States.